Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Operating Margin: 2024-2025

Historic Operating Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -385.53%.

  • Kura Oncology's Operating Margin fell 1492048.00% to -385.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -482.11%, marking a year-over-year change of. This contributed to the annual value of -358.55% for FY2024, which is 1106248.00% down from last year.
  • Kura Oncology's Operating Margin amounted to -385.53% in Q3 2025, which was up 18.89% from -475.31% recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Operating Margin registered a high of 14,534.95% during Q3 2024, and its lowest value of -475.31% during Q2 2025.
  • In the last 2 years, Kura Oncology's Operating Margin had a median value of 5,571.96% in 2024 and averaged 6,623.07%.
  • Data for Kura Oncology's Operating Margin shows a maximum YoY plummeted of 1,492,048bps (in 2025) over the last 5 years.
  • Kura Oncology's Operating Margin (Quarterly) stood at 5,571.96% in 2024, then slumped by 1,492,048bps to -385.53% in 2025.
  • Its Operating Margin was -385.53% in Q3 2025, compared to -475.31% in Q2 2025 and -458.61% in Q1 2025.